CrossrefInfokarte
Prognostic Value of Baseline Metabolic Tumor Volume on [18F]FDG PET/CT in Metastatic Breast Cancer Treated With CDK4/6 Inhibitors
Clinical Breast Cancer · 2026-11 · 26 (11) · 25-31
DOI: 10.1016/j.clbc.2026.09.009 ↗Abstract
Kein Abstract verfügbar.
EUVIMED